• Biosciences Accelerator Companies Flourish

    A summer which featured a company launch, an NIH grant awardee, and an acquisition highlight a flurry of progress for The Hamner Biosciences Accelerator


  • The Hamner Releases DILIsym® v4B

    Non-profit research institute announces the release of the latest version of its flagship DILI platform


  • The Hamner Launches DILIsym Services, Inc.

    The Hamner’s first spinout will focus on proprietary simulation projects for pharma


The Hamner performs cutting-edge research to improve chemical and drug safety and speed the development of new breakthrough medicines.

The Hamner Institutes for Health Sciences brings together safety assessments for chemicals and drugs, world-class education and training, and accelerated technology development on a single, multidisciplinary campus in the heart of North Carolina's Research Triangle.

With a commitment to innovation, public-private partnerships, and the creation of a global biosciences gateway, The Hamner strives to be "the translational research model for the 21st century."


A Framework For Visualizing Toxicity Pathways

The Hamner computational biology and bioinformatics team is developing new tools to make genomic data more intuitive

Learn More

Upcoming Events See all events